Next Generation Sequencing (NGS) Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Next Generation Sequencing (NGS) Market By Product (Consumables, Instruments, Software and Services)  By Application (Clinical Diagnosis, Drug Discovery, Biomarker Discovery and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies) By Workflow (Pre-Sequencing, Sequencing, NGS Data Analysis) By End User (Academic Institutes & Research Centres, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Next generation sequencing market was valued 9.5 Billion in 2020 and is expected to grow at US$ 27.67 Billion at a CAGR of 16.5% by 2027 over the forecast period. Improvising cost related to NGS platforms and improving regulatory framework and reimbursement scenario for particular diagnosis tests related to NGS are the key drivers leading the market with low cost, high speed, accuracy are main advantages. Lack of skilled professionals, ethical and legal limitations are the resistance. New technology with include machine learning, predictive algorithms, automation of global analytic libraries, data scientists anticipate a multiple opportunity toward the global next-generation sequencing market.

Global next generation sequencing market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes on the basis of product type, application, technology, end user, and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global next generation sequencing market


Next Generation Sequencing (NGS) Market

MARKET SUMMARY
-
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 16.5%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Next Generation Sequencing (NGS) Market

  • Market players have witnessed the strategic collaboration and acquisition to expand product portfolio and strengthen their position in the market to enhance the revenue of the company.
  • In June 2018, Thermo Fisher Scientific (US) offers sequencers that run on its Ion semiconductor technology (the second-largest segment of the technologies market). The company also offers reagents & consumables, software, and services for NGS research.
  • Global next generation sequencing market expanding at significant CAGR over 2021 to 2027 owing due to increase in the rate number of people who required individualistic drug treatment
  • Based on region, North America accounted for larger market revenue share in 2020 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global market
Market Leaders
  • Illumina, Inc.
  • BGI Group
  • PerkinElmer Inc.
  • Macrogen
  • Hamilton Company
  • Lucigen
  • Intrexon Bioinformatics GmbH
  • Partek Incorporated
Next Generation Sequencing (NGS) Market

Drivers and Restraints

It is noticed that the global next generation sequencing market is influenced mainly by the number of people who required individualized drug treatment which is the key factor causing the next generation sequencing market to grow. This trend is estimated to boost the next generation sequencing market over a next era. People are well aware of the facts and benefits pertaining of NGS. There is considerable number of rises in patients who ask the physician for NGS test seeking early detection or prevention of some deadly diseases. Hence there are around 16.1 million of people who currently need the global next generation sequencing market to find a better alternative for their problem.


Next Generation Sequencing (NGS) Market

North America dominates the market

North America contributed major revenue followed by Europe and Asia Pacific. North America dominated the market by high investment in R&D due to increase in cancer patients. Key role is played by innovations in genetic disease diagnosis and government bodies, consequently boosting the uptake of next generation sequencing technology. Europe led the market secondly by prominent market players and collaborations. Asia Pacific grow at CAGR of 20.7 %, obtained by simultaneous funding by government and private organization for innovative technology and biotechnology boosting the global next generation sequencing market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Next Generation Sequencing (NGS) Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Illumina, Inc.
  • BGI Group
  • PerkinElmer Inc.
  • Macrogen
  • Hamilton Company
  • Lucigen
  • Intrexon Bioinformatics GmbH
  • Partek Incorporated
  • DNASTAR, Inc.
  • DNAnexus
  • Hoffmann-La Roche Ltd.
  • Becton Dickinson and Company
  • Danaher
  • Oxford Nanopore Technologies
  • Agilent Technologies, Inc.

Description

Next generation sequencing market was valued 9.5 Billion in 2020 and is expected to grow at US$ 27.67 Billion at a CAGR of 16.5% by 2027 over the forecast period. Improvising cost related to NGS platforms and improving regulatory framework and reimbursement scenario for particular diagnosis tests related to NGS are the key drivers leading the market with low cost, high speed, accuracy are main advantages. Lack of skilled professionals, ethical and legal limitations are the resistance. New technology with include machine learning, predictive algorithms, automation of global analytic libraries, data scientists anticipate a multiple opportunity toward the global next-generation sequencing market.

Global next generation sequencing market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes on the basis of product type, application, technology, end user, and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global next generation sequencing market

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX